S&P 500   3,310.11 (+1.19%)
DOW   26,659.11 (+0.52%)
QQQ   276.39 (+1.75%)
AAPL   115.32 (+3.71%)
MSFT   204.72 (+1.01%)
FB   280.83 (+4.92%)
GOOGL   1,556.88 (+3.05%)
AMZN   3,211.01 (+1.52%)
TSLA   410.83 (+1.18%)
NVDA   520.96 (+3.14%)
BABA   312.56 (+1.50%)
CGC   18.78 (+2.40%)
GE   7.37 (-0.67%)
MU   50.48 (+0.96%)
AMD   78.02 (+2.12%)
T   26.76 (+0.98%)
F   7.90 (+2.60%)
ACB   4.09 (+6.79%)
GILD   58.53 (-0.32%)
NFLX   504.21 (+3.70%)
NIO   31.99 (+16.28%)
BA   148.29 (+0.10%)
DIS   121.54 (+2.59%)
S&P 500   3,310.11 (+1.19%)
DOW   26,659.11 (+0.52%)
QQQ   276.39 (+1.75%)
AAPL   115.32 (+3.71%)
MSFT   204.72 (+1.01%)
FB   280.83 (+4.92%)
GOOGL   1,556.88 (+3.05%)
AMZN   3,211.01 (+1.52%)
TSLA   410.83 (+1.18%)
NVDA   520.96 (+3.14%)
BABA   312.56 (+1.50%)
CGC   18.78 (+2.40%)
GE   7.37 (-0.67%)
MU   50.48 (+0.96%)
AMD   78.02 (+2.12%)
T   26.76 (+0.98%)
F   7.90 (+2.60%)
ACB   4.09 (+6.79%)
GILD   58.53 (-0.32%)
NFLX   504.21 (+3.70%)
NIO   31.99 (+16.28%)
BA   148.29 (+0.10%)
DIS   121.54 (+2.59%)
S&P 500   3,310.11 (+1.19%)
DOW   26,659.11 (+0.52%)
QQQ   276.39 (+1.75%)
AAPL   115.32 (+3.71%)
MSFT   204.72 (+1.01%)
FB   280.83 (+4.92%)
GOOGL   1,556.88 (+3.05%)
AMZN   3,211.01 (+1.52%)
TSLA   410.83 (+1.18%)
NVDA   520.96 (+3.14%)
BABA   312.56 (+1.50%)
CGC   18.78 (+2.40%)
GE   7.37 (-0.67%)
MU   50.48 (+0.96%)
AMD   78.02 (+2.12%)
T   26.76 (+0.98%)
F   7.90 (+2.60%)
ACB   4.09 (+6.79%)
GILD   58.53 (-0.32%)
NFLX   504.21 (+3.70%)
NIO   31.99 (+16.28%)
BA   148.29 (+0.10%)
DIS   121.54 (+2.59%)
S&P 500   3,310.11 (+1.19%)
DOW   26,659.11 (+0.52%)
QQQ   276.39 (+1.75%)
AAPL   115.32 (+3.71%)
MSFT   204.72 (+1.01%)
FB   280.83 (+4.92%)
GOOGL   1,556.88 (+3.05%)
AMZN   3,211.01 (+1.52%)
TSLA   410.83 (+1.18%)
NVDA   520.96 (+3.14%)
BABA   312.56 (+1.50%)
CGC   18.78 (+2.40%)
GE   7.37 (-0.67%)
MU   50.48 (+0.96%)
AMD   78.02 (+2.12%)
T   26.76 (+0.98%)
F   7.90 (+2.60%)
ACB   4.09 (+6.79%)
GILD   58.53 (-0.32%)
NFLX   504.21 (+3.70%)
NIO   31.99 (+16.28%)
BA   148.29 (+0.10%)
DIS   121.54 (+2.59%)
Log in
NYSE:ACB

Aurora Cannabis Stock Forecast, Price & News

$4.09
+0.26 (+6.79 %)
(As of 10/29/2020 05:14 PM ET)
Add
Compare
Today's Range
$3.80
Now: $4.09
$4.09
50-Day Range
$4.00
MA: $5.38
$7.65
52-Week Range
$3.71
Now: $4.09
$47.04
Volume7.78 million shs
Average Volume6.59 million shs
Market Capitalization$472.35 million
P/E RatioN/A
Dividend YieldN/A
Beta1.79
Aurora Cannabis Inc. produces and distributes medical cannabis products worldwide. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, including facility engineering and design, cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories, including valves, screens, etc.; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and ROAR Sports. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.9Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.52 out of 5 stars

Industry, Sector and Symbol

Industry Medicinals & botanicals
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone1-855-279-4652
Employees2,731

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$207.89 million
Book Value$13.73 per share

Profitability

Net Income$-2,468,190,000.00
Net Margins-1,158.72%

Miscellaneous

Market Cap$472.35 million
Next Earnings Date11/9/2020 (Confirmed)
OptionableOptionable
$4.09
+0.26 (+6.79 %)
(As of 10/29/2020 05:14 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ACB News and Ratings via Email

Sign-up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Aurora Cannabis (NYSE:ACB) Frequently Asked Questions

How has Aurora Cannabis' stock been impacted by Coronavirus?

Aurora Cannabis' stock was trading at $10.3044 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, ACB stock has decreased by 60.8% and is now trading at $4.04.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Aurora Cannabis?

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aurora Cannabis in the last year. There are currently 3 sell ratings, 13 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Aurora Cannabis
.

When is Aurora Cannabis' next earnings date?

Aurora Cannabis is scheduled to release its next quarterly earnings announcement on Monday, November 9th 2020.
View our earnings forecast for Aurora Cannabis
.

How were Aurora Cannabis' earnings last quarter?

Aurora Cannabis Inc. (NYSE:ACB) announced its quarterly earnings results on Thursday, November, 14th. The company reported $0.12 earnings per share for the quarter, beating the Zacks' consensus estimate of ($0.36) by $0.48. The firm had revenue of $57.02 million for the quarter, compared to analyst estimates of $72.82 million. Aurora Cannabis had a negative net margin of 1,158.72% and a negative return on equity of 10.45%.
View Aurora Cannabis' earnings history
.

When did Aurora Cannabis' stock split? How did Aurora Cannabis' stock split work?

Shares of Aurora Cannabis reverse split on Monday, May 11th 2020. The 1-12 reverse split was announced on Friday, May 8th 2020. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 8th 2020. An investor that had 100 shares of Aurora Cannabis stock prior to the reverse split would have 8 shares after the split.

What guidance has Aurora Cannabis issued on next quarter's earnings?

Aurora Cannabis updated its first quarter 2021 After-Hours earnings guidance on Tuesday, September, 22nd. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $43.278-46.163 million.

What price target have analysts set for ACB?

17 brokers have issued twelve-month price targets for Aurora Cannabis' shares. Their forecasts range from $3.60 to $24.00. On average, they expect Aurora Cannabis' stock price to reach $12.84 in the next year. This suggests a possible upside of 217.8% from the stock's current price.
View analysts' price targets for Aurora Cannabis
.

Are investors shorting Aurora Cannabis?

Aurora Cannabis saw a decline in short interest during the month of October. As of October 15th, there was short interest totaling 23,490,000 shares, a decline of 17.1% from the September 30th total of 28,340,000 shares. Based on an average daily trading volume, of 7,480,000 shares, the short-interest ratio is presently 3.1 days. Approximately 19.5% of the shares of the company are sold short.
View Aurora Cannabis' Short Interest
.

Who are some of Aurora Cannabis' key competitors?

What other stocks do shareholders of Aurora Cannabis own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aurora Cannabis investors own include Canopy Growth (CGC), Cronos Group (CRON), Aphria (APHA), NVIDIA (NVDA), HEXO (HEXO), Tilray (TLRY), Alibaba Group (BABA), Advanced Micro Devices (AMD), General Electric (GE) and Micron Technology (MU).

Who are Aurora Cannabis' key executives?

Aurora Cannabis' management team includes the following people:
  • Mr. Michael Singer, Exec. Chairman (Age 55)
  • Mr. Glen Ibbott, Chief Financial Officer
  • Mr. Allan John Cleiren C.P.A., C.A., ICD.D., Chief Operating Officer
  • Ms. Jillian Swainson, Chief Legal Officer & Corp. Sec.
  • Mr. Miguel Martin, CEO & Director (Age 48)
  • Mr. Darryl Vleeming, Exec. VP of Information Services
  • Dr. Jonathan Page Ph.D., Chief Science Officer (Age 51)
  • Ananth Krishnan, VP of Capital Markets & Investor Relations
  • Michelle Lefler, VP of Communications & PR
  • Mr. Carey Squires, Exec. VP, Corp. Devel. & Strategy

What is Aurora Cannabis' stock symbol?

Aurora Cannabis trades on the New York Stock Exchange (NYSE) under the ticker symbol "ACB."

Who are Aurora Cannabis' major shareholders?

Aurora Cannabis' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Alberta Investment Management Corp (0.05%), Cambridge Investment Research Advisors Inc. (0.03%), Wedbush Securities Inc. (0.03%), Kessler Investment Group LLC (0.03%) and Centric Wealth Management (0.01%).

Which institutional investors are selling Aurora Cannabis stock?

ACB stock was sold by a variety of institutional investors in the last quarter, including Cambridge Investment Research Advisors Inc., and Kessler Investment Group LLC.

Which institutional investors are buying Aurora Cannabis stock?

ACB stock was bought by a variety of institutional investors in the last quarter, including Alberta Investment Management Corp, Wedbush Securities Inc., and Centric Wealth Management.

How do I buy shares of Aurora Cannabis?

Shares of ACB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Aurora Cannabis' stock price today?

One share of ACB stock can currently be purchased for approximately $4.04.

How big of a company is Aurora Cannabis?

Aurora Cannabis has a market capitalization of $466.58 million and generates $207.89 million in revenue each year. The company earns $-2,468,190,000.00 in net income (profit) each year or ($2.86) on an earnings per share basis. Aurora Cannabis employs 2,731 workers across the globe.

What is Aurora Cannabis' official website?

The official website for Aurora Cannabis is auroramj.com.

How can I contact Aurora Cannabis?

Aurora Cannabis' mailing address is 10355 JASPER AVENUE SUITE 500, EDMONTON A0, T5J 1Y6. The company can be reached via phone at 1-855-279-4652 or via email at [email protected]

This page was last updated on 10/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.